A detailed history of Lfa Lugano Financial Advisors Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lfa Lugano Financial Advisors Sa holds 150 shares of GILD stock, worth $13,212. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150
Previous 150 -0.0%
Holding current value
$13,212
Previous $10,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

BUY
$76.01 - $86.7 $11,401 - $13,005
150 New
150 $11,000
Q3 2020

Oct 23, 2020

SELL
$62.1 - $78.08 $171,396 - $215,500
-2,760 Closed
0 $0
Q3 2018

Oct 11, 2018

BUY
$71.28 - $78.92 $110,056 - $121,852
1,544 Added 126.97%
2,760 $213,000
Q2 2018

Sep 04, 2018

SELL
$64.88 - $75.68 $5.47 Million - $6.38 Million
-84,318 Reduced 98.58%
1,216 $86,000
Q2 2018

Aug 30, 2018

BUY
$64.88 - $75.68 $5.55 Million - $6.47 Million
85,534 New
85,534 $86,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Lfa Lugano Financial Advisors Sa Portfolio

Follow Lfa Lugano Financial Advisors Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lfa Lugano Financial Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lfa Lugano Financial Advisors Sa with notifications on news.